Medical Equipment

Qilu Pharmaceutical Releases Latest Results of QL1604 plus Chemotherapy as First-Line Treatment for Patients with Advanced Cervical Cancer in the Phase II Study at ESMO Asia Congress 2022

JINAN, China, Dec. 4, 2022 /PRNewswire/ -- Qilu Pharmaceutical, one of the leading vertically integrated pharmaceutical companies inChina that develops, manufactures, and distributes both finished formulations and Active Pharmaceutical Ingredients, announced that the results of the phase II study...

2022-12-04 17:00 2187

JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential

SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing the potential for 3D imaging and AI to be the future of cancer pathology. Presently, most cancer diagnosis is done through thinly sliced physic...

2022-12-03 09:58 3317

Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus

SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- Lakeshore Acquisition I Corp. (Nasdaq: LAAA) ("Lakeshore") today announced that its shareholders have approved all proposals related to the previously announced business combination (the "Business Combination") with ProSomnus Holdings, Inc. ("ProSomnus"...

2022-12-03 05:05 4849

Epiprotect reduces the cost for treatment of hard to heal leg ulcers with 83%

LINKÖPING, Sweden, Dec. 3, 2022 /PRNewswire/ -- A compilation of data from patients treated at S2Clinic during the period 2019-2022 showed that the cost of treatment of these patients was reduced by approximately 83% compared to conventional treatment. The treatment with Epiprotect also resulted ...

2022-12-03 00:41 3641

Armis Named Clear Leader in SPARK Matrix for Connected Medical Device Security Solutions

Company recognized for comprehensive and robust asset intelligence platform; ranked highest among competitors for technology excellence and customer impact SAN FRANCISCO, Dec. 1, 2022 /PRNewswire/ -- Armis, the leading asset visibility and security company, today announced that it has been named ...

2022-12-01 22:50 2942

S3 Connected Health Receives Frost & Sullivan's Award for Helping Medical Device Companies Create Custom Connected Medical Device Solutions

S3 Connected Health supports its partners and clients by defining optimal solutions that address their unique needs and constraints, taking customers from concept to development, operation, and lifecycle management SAN ANTONIO, Nov. 30, 2022 /PRNewswire/ -- Recently, Frost & Sullivan analyzed th...

2022-11-30 23:59 2811

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

LONDON and HONG KONG, Nov. 30, 2022 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced that its board of directors has authorized a share repurchase program, and that it has been included as a c...

2022-11-30 22:15 4322

Cardiac Troponin Diagnostics Market Growth Boosted by High-sensitivity Point-of-care Testing

The rise in emergency department visits due to cardiac complaints drives the demand for cTn biomarkers SAN ANTONIO, Nov. 30, 2022 /PRNewswire/ -- The global demand for cardiac troponin (cTn) diagnostics biomarkers is increasing as more patients with cardiac complaints are visiting emergency depa...

2022-11-30 16:12 1909

United Imaging Selected to Academy of Radiology & Biomedical Imaging Research's Council of Distinguished Investigators' Class of 2022

United Imaging's Chief Technology Officer recognized at a ceremony and reception during RSNA onTuesday, November 29, 2022.  HOUSTON, Nov. 29, 2022 /PRNewswire/ -- United Imaging, a global leader in producing advanced medical imaging and radiotherapy equipment, is welcomed today to the Distinguis...

2022-11-29 22:00 3430

Etiometry Applauded by Frost & Sullivan for Enabling Timely Decision Support for Critical Care with Its Digital and Automated Solution

The Etiometry Platform elevates clinical staff performance and identifies areas requiring urgent attention for better clinical outcomes, shorter hospital stays, and enhanced revenue opportunities. SAN ANTONIO, Nov. 29, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the US clinical decis...

2022-11-29 21:00 3191

Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline

Acquisition accelerates Full-Life's transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Development Platform BRUSSELS and WATCHUNG, N.J. and SHANGHAI, Nov. 28, 2022 /PRNewswire/ -- Full-Life Technologies, a fully integrated global r...

2022-11-29 10:00 3464

Cambridge Cognition and Luca Healthcare Announce a Strategic Partnership and an Exclusive Licensing Agreement to Commercialize Cambridge Cognition's Suite of Cognitive Assessment Tools and Brain Health Products for the China Market

SHANGHAI, Nov. 28, 2022 /PRNewswire/ -- Cambridge Cognition, a leading technology company, which develops and markets digital solutions to assess brain health, and Luca Healthcare,China's category leader in developing and commercializing clinically validated digital health solutions, today annou...

2022-11-29 10:00 2958

Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan

NEW TAIPEI CITY, Taiwan, Nov. 28, 2022 /PRNewswire/ -- Medeologix, a Taiwan MedTech CDMO company announces its successful acquisition of three premier medical device manufacturing companies to form an integrated full function service group. The newly formed Medeologix family of companies, with a ...

2022-11-28 21:00 5432

SeekIn Receives CE-IVD Mark Approval for SeekInCure® Cancer Recurrence Monitoring Kit

First-of-its-kind blood-based pan-cancer recurrence monitoring test SHENZHEN, China, Nov. 28, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for SeekInCure® Cancer Recurrence Moni...

2022-11-28 21:00 4188

VUNO Showcases their AI Solutions and Research Results at RSNA 2022

SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- VUNO Inc., a leading South Korean artificial intelligence (AI) developer, announced that it will participate in the Radiological Society ofNorth America 2022 (RSNA 2022). This year, VUNO will focus on highlighting how their breakthrough AI technol...

2022-11-25 23:00 14230

New study on deep learning technology for improving MRI image quality published in European Radiology

SwiftMR™, an AI-powered MRI reconstruction solution from AIRS Medical proved its performance for enhancing the image quality of 3D high-resolution MRI SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- A recent study published in European Radiology

2022-11-25 23:00 14010

Neurophet, to participate in the Radiological Society of North America RSNA 2022

̵ Introducing 4 products at the booth including the main product Neurophet AQUA ̵ Conducting in-depth discussions jointly team members from R&D and cooperation with several global companies SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution comp...

2022-11-25 22:00 13063

Concord Medical Schedules 2022 Annual Meeting of Shareholders

BEIJING, Nov. 25, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensi...

2022-11-25 19:30 12852

Venus Medtech to showcase its structural heart treatments at London Valves 2022

The company's growing number of solutions for structural heart disease will be presented at multiple events during the conference betweenNovember 27-29 HANGZHOU, China, Nov. 25, 2022 /PRNewswire/ -- Venus Medtech is building an exciting pipeline of treatments for structural heart disease. The co...

2022-11-25 18:08 8254

XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation

AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide HONG KONG and SHENZHEN, China, Nov. 25, 2022 /PRNewswire/ -- XtalPi announced today that they are embarking on a strategic collaboration with CK ...

2022-11-25 09:49 4105
1 ... 116117118119120121122 ... 148